Established Investigator Awards
Memory T cell responses in primary melanoma
MRA Established Investigator Award, collaboratively funded by University of Michigan
Christina Angeles MD, The University of Michigan
Armoring CD8+ T cells against energetic deficiency in melanoma
Leveraged Finance Fights Melanoma — MRA Established
Investigator Award
Timothy Bullock PhD, University of Virginia
Therapeutic targeting of Hdm2/HdmX E3 ligase in melanoma
MRA Established Investigator Award
Julio Camarero PhD, University of Southern California
Genetic mechanisms early melanoma progression
Anna-Maria and Stephen Kellen Foundation — MRA Established
Investigator Award
Adam Dupuy PhD, The University of Iowa
Sohail Tavazoie, MD, PhD — The Rockefeller University
David Lombard, MD, PhD — University of Miami
Mechanisms underlying the oncogenic role of ORAI2 in melanoma
MRA Established Investigator Award
Stefan Feske MD, New York University Grossman School of Medicine
Dissecting the mechanisms of melanoma cell adaptation to the brain
MRA Established Investigator Award
Eva Hernando PhD, New York University Grossman School of Medicine
Precision, plasma-only, melanoma ctDNA residual disease monitoring
Ellen and Gary Davis — MRA Established Investigator Award
Dan Landau MD, PhD, Weill Medical College of Cornell University
Sustaining metabolic fitness of antitumor CD8+ T cells
MRA Established Investigator Award
Bin Zhang MD, PhD, Northwestern University